Trial Profile
Efficacy and Safety of Dalbavancin in a Subgroup of Patients Who Inject Drugs/Homeless Persons: A Retrospective Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Oct 2017
Price :
$35
*
At a glance
- Drugs Dalbavancin (Primary)
- Indications Staphylococcal infections
- Focus Therapeutic Use
- 26 Oct 2017 New trial record
- 08 Oct 2017 Results related to persons who inject drug (PWID) subgroup were presented at the IDWeek 2017